Many other urinary and serum biomarkers predicting AKI outcomes have been found, for instance, neutrophil gelatinase-associated lipocalin (NGAL), L-type fatty acid-binding protein (L-FABP), kidney injury molecule-1 (KIM-1), tissue inhibitor of metalloproteinases 2 (TIMP-2), insulin-like growth factor-binding protein 7 (IGFBP7), cystatin C, netrin-1, and uromodulin (UMOD) (10–12). The gene discussed is TIMP2; the disease is acute kidney injury.